ImmunoPrecise Antibodies Ltd. 3204-4464 Markham Street Victoria, BC, Canada V8Z 7X8 PH: +1 (250) 483-0308 Website: www.ipatherapeutics.com Email: info@ipatherapeutics.com Date
Friday, August 1, 2025 1 min read
Key Takeaway: ImmunoPrecise Antibodies Ltd. announced its upcoming Annual General Meeting, scheduled for October 9, 2025. The record date for notice and voting is set for August 27, 2025. The meeting will be held virtually, and materials related to the meeting will not be sent directly to Non-Registered Owners. This announcement serves as a formal communication to all relevant securities regulatory authorities and stakeholders.
To: All Canadian Securities Regulatory Authorities NASDAQ Exchange
Subject: IMMUNOPRECISE ANTIBODIES LTD.
Dear Sir/Madam: We advise of the following with respect to the upcoming Meeting of Security Holders for the subject Issuer:
Meeting Type : Annual General Meeting Record Date for Notice of Meeting : August 27, 2025 Record Date for Voting (if applicable) : August 27, 2025 Beneficial Ownership Determination Date: August 27, 2025 Meeting Date : October 9, 2025 Meeting Location (if available) : Virtual Meeting Issuer sending proxy related materials directly to NOBO: No Issuer paying for delivery to OBO: No Notice and Access (NAA) Requirements: NAA for Beneficial Holders No NAA for Registered Holders No
Voting Security Details:
Description CUSIP Number ISIN COMMON 45257F200 CA45257F2008
Sincerely, IMMUNOPRECISE ANTIBODIES LTD.
Frequently Asked Questions
What is the date of ImmunoPrecise's Annual General Meeting?
The Annual General Meeting is scheduled for October 9, 2025.
When is the record date for voting at the meeting?
The record date for voting is August 27, 2025.
Where will the meeting be held?
The meeting will be conducted as a virtual meeting.
What is the CUSIP number for ImmunoPrecise common shares?
The CUSIP number is 45257F200.
Is there a Notice and Access requirement for registered holders?
No, there is no Notice and Access requirement for registered holders.